Avastin Wins New Colorectal Ca Indication

(MedPage Today) -- The FDA has approved a new use of bevacizumab (Avastin) as part of second-line combination therapy for metastatic colorectal cancer, the drug's manufacturer announced.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news